OVARY NEOPLASM
Clinical trials for OVARY NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new OVARY NEOPLASM trials appear
Sign up with your email to follow new studies for OVARY NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early cancer drug trial halted before key testing phase
Disease control TerminatedThis early-stage study tested a new oral cancer drug called NUV-868, both alone and combined with existing medications (olaparib or enzalutamide), in adults with advanced solid tumors. The trial aimed to find safe doses and see if these treatments could help control cancers that …
Matched conditions: OVARY NEOPLASM
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists reprogram Patients' own cells to hunt cancer
Disease control TerminatedThis early-stage study tested a personalized cancer treatment that modifies a patient's own immune cells to recognize and attack their specific tumor mutations. The trial enrolled 8 adults with advanced solid tumors (including ovarian, lung, pancreatic, and colorectal cancers) wh…
Matched conditions: OVARY NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Alaunos Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC